Search alternatives:
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
-
17821
-
17822
AHA Scientific Sessions Poster 2019
Published 2024“…Additional studies in LDLr KO mice indicate that selectively targeting LXR in the gut with inverse agonists significantly decrease total and LDL cholesterol (n=12). We believe that this is an innovative method of targeting hypercholesterolemia and may lead to a new class of atherosclerosis therapeutics.…”
-
17823
Data_Sheet_1_Frequent, Short Physical Activity Breaks Reduce Prefrontal Cortex Activation but Preserve Working Memory in Middle-Aged Adults: ABBaH Study.docx
Published 2021“…The effects on working memory, psychological factors, and blood glucose were also examined, and whether arterial stiffness moderated prefrontal cortex activation. Thirteen subjects (mean age 50.5 years; eight men) underwent three 3-h sitting conditions, interrupted every 30-min by a different 3-min break on separate, randomized-ordered days: seated social interactions (SOCIAL), walking (WALK), or simple resistance activities (SRA). …”
-
17824
Figure CSA-2 4.15
Published 2019“…</div><div><br></div><div>As in the perfect case, both the mean error and standard deviations clearly decrease with the addition of the MW data. …”
-
17825
<i>Oxtr</i> promoter methylation changes <i>in vivo</i>.
Published 2013“…A general increase is observed in the mammary glands while a general decrease is evident in the uterus. …”
-
17826
Mistaken inference becomes less likely with experience, as subjects learn to use past evidence.
Published 2019“…(<b>C</b>) By calculating <i>γ</i> for each tertile we find that 4/6 subjects show a significant decrease in the MLE estimate of <i>γ</i> from the first to last tertiles, with the remaining two subjects showing no significant change (permutation test; <i>h</i><sub>12</sub>). …”
-
17827
Origanum Syriacum Inhibits Proliferation, Migration, Invasion and Induces Differentiation of Human Aortic Smooth Muscle Cells
Published 2014“…OSEE has shown to significantly decrease the invasive capacity of HASMCs by 79.82 ± 5.69% compared to control. …”
Get full text
Get full text
-
17828
Minerals balance and performance of broilers at 21 days of age fed diet containing Solanum malacoxylon
Published 2018“…Using 5.0g of SM/kg diet reduced weight gain, decreased feed conversion, although consumption has not been affected. …”
-
17829
Differentiation outcomes and gene expression from EPL cells cultured in an FGF signalling inhibitor.
Published 2010“…(<b>B</b>) Differentiation outcomes from EPL cells cultured in serum-containing medium supplemented with 50 and 75 nM PD173074. Addition of PD173074 resulted in a significant decrease in cardiomyocytes and blood and a significant increase in neuron formation. n = 3. * indicates a significant increase (p<0.05) when compared to serum + DMSO. # indicates a significant decrease (p<0.05) when compared to serum + DMSO. …”
-
17830
Neutralization breadth and potency of top 5 nanobodies against 25 diverse sarbecoviruses.
Published 2024“…<p><b>a.</b> Nanobody concentrations (μg/ml) required to achieve 50% (IC50) and 90% (IC90) reduction in viral infection. …”
-
17831
[Ca<sup>2+</sup>]<sub>i</sub> oscillations during stimulation with 12 mM glucose.
Published 2013“…Y axis represents the normalized fraction of the difference between maximum and plateau baseline fluorescence. <b>D</b> A pseudo-colored representation of time lags between oscillation end<sub>50</sub> in the cell in which [Ca<sup>2+</sup>]<sub>i</sub> decreased first and every other cell. …”
-
17832
-
17833
-
17834
<b>Supporting data for ''The pathogenicity and pathogenic mechanism of SARS-CoV-2 Omicron''</b>
Published 2025“…However, the intrinsic pathogenicity and replication fitness of the post-BA.2/5 subvariants remain incompletely understood. We systematically evaluated the replication fitness and intrinsic pathogenicity of representative post-BA.2/5 subvariants (BL.1, BQ.1, BQ.1.1, XBB.1, CH.1.1, and XBB.1.5) in weanling (3–4 weeks), adult (8–10 weeks), and aged (10–12 months) mice. …”
-
17835
-
17836
-
17837
Proteasome function is required for AMPA-induced depotentiation of synaptosomes.
Published 2013“…After 10 min., samples were treated with either the proteasome inhibitor MG-132 (50 µM), lactacystin (10 µM) or control buffer, followed by AMPA (100 µM) for 30 min. to depotentiate synaptosomes as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0006021#pone-0006021-g004" target="_blank">figure 4B</a>. …”
-
17838
Supplementary Material for: Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to...
Published 2020“…We also studied the effects of potential confounders on MACE decrease. …”
-
17839
<i>Pf</i>PKA-mediated phosphorylation contributes to immature GIE stiffness.
Published 2015“…Decrease of <i>Pf</i>PKA-R expression in absence of pyrimethamine (- pyr) indicates a loss of episomal expression of the <i>Pf</i>PKA-R protein. …”
-
17840
Data Sheet 1_Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus.pdf
Published 2025“…There was no significant change in hemoglobin A1c level over time. FLI (mean ± standard deviation: 68.1 ± 21.9 vs. 39.6 ± 25.0, P < 0.001), but not FIB-4 index as a marker of hepatic fibrosis (median [interquartile range]: 1.04 [0.78-1.39] vs. 1.01 [0.68-1.36], P = 0.909), was significantly decreased by treatment with pemafibrate for 12M, and the proportion of patients with metabolic dysfunction-associated SLD (MASLD) was significantly decreased from 92.3% (baseline) to 61.5% (12M).…”